GNRH Receptor

Choose Selective GNRH Receptor Inhibitors

GNRH Receptor Products

  • All (5)
  • GNRH Receptor Antagonists (2)
  • GNRH Receptor Agonists (3)
  • New GNRH Receptor Products
Catalog No. Product Name Information Product Use Citations Product Validations
S4896 Elagolix Sodium Elagolix Soidum (NBI-56418, ABT-620) is a potent, selective, orally active, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) with Kd value of 54 pM. Concentration at 10 μM shows no significant activity on ion channels, enzymes, and transporters (inhibition <50%).
J Int Med Res, 2022, 50(3):3000605221082895
Nat Commun, 2020, 11(1):5287
S5808 Relugolix Relugolix (RVT-601, TAK-385) is a selective antagonist of the gonadotropin-releasing hormone receptor (GnRHR) with IC50 of 0.33 nM and 0.32 nM for human GnRHR and monkey GnRHR, respectively.
P1089 Goserelin Acetate Goserelin is a luteinizing hormone releasing hormone (LHRH) agonist, which is used to suppress production of the sex hormones. Goserelin acetate is an injectable gonadotropin releasing hormone superagonist (GnRH agonist).
P1093New Deslorelin Acetate

Deslorelin Acetate is a synthetic analogue of gonadotrophin-releasing hormone (GnRH) that acts as a potent GnRH agonist.

S3718 Leuprolide Acetate Leuprolide acetate (Leuprorelin) is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques.
J Int Med Res, 2022, 50(3):3000605221082895
S4896 Elagolix Sodium Elagolix Soidum (NBI-56418, ABT-620) is a potent, selective, orally active, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) with Kd value of 54 pM. Concentration at 10 μM shows no significant activity on ion channels, enzymes, and transporters (inhibition <50%).
J Int Med Res, 2022, 50(3):3000605221082895
Nat Commun, 2020, 11(1):5287
S5808 Relugolix Relugolix (RVT-601, TAK-385) is a selective antagonist of the gonadotropin-releasing hormone receptor (GnRHR) with IC50 of 0.33 nM and 0.32 nM for human GnRHR and monkey GnRHR, respectively.
P1089 Goserelin Acetate Goserelin is a luteinizing hormone releasing hormone (LHRH) agonist, which is used to suppress production of the sex hormones. Goserelin acetate is an injectable gonadotropin releasing hormone superagonist (GnRH agonist).
P1093New Deslorelin Acetate

Deslorelin Acetate is a synthetic analogue of gonadotrophin-releasing hormone (GnRH) that acts as a potent GnRH agonist.

S3718 Leuprolide Acetate Leuprolide acetate (Leuprorelin) is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques.
J Int Med Res, 2022, 50(3):3000605221082895
P1093New Deslorelin Acetate

Deslorelin Acetate is a synthetic analogue of gonadotrophin-releasing hormone (GnRH) that acts as a potent GnRH agonist.

Tags: GNRH Receptor inhibitor|GNRH Receptor agonist|GNRH Receptor activator|GNRH Receptor inducer|GNRH Receptor antagonist|GNRH Receptor signaling pathway|GNRH Receptor assay kit